GRISENDI, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 13.025
EU - Europa 7.805
AS - Asia 5.982
SA - Sud America 957
AF - Africa 148
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 5
Totale 27.975
Nazione #
US - Stati Uniti d'America 12.778
SE - Svezia 2.338
SG - Singapore 2.024
IT - Italia 1.923
CN - Cina 1.472
GB - Regno Unito 1.372
VN - Vietnam 729
HK - Hong Kong 713
BR - Brasile 678
DE - Germania 567
RU - Federazione Russa 312
FI - Finlandia 267
FR - Francia 254
UA - Ucraina 175
TR - Turchia 153
ID - Indonesia 148
KR - Corea 142
IN - India 123
CA - Canada 109
MX - Messico 92
AR - Argentina 91
NL - Olanda 86
BG - Bulgaria 84
BD - Bangladesh 69
IE - Irlanda 61
IQ - Iraq 56
BE - Belgio 54
JP - Giappone 53
AU - Australia 51
PL - Polonia 50
ES - Italia 48
EC - Ecuador 44
ZA - Sudafrica 43
VE - Venezuela 40
PK - Pakistan 34
AE - Emirati Arabi Uniti 32
CL - Cile 30
CO - Colombia 26
UZ - Uzbekistan 26
CZ - Repubblica Ceca 25
AL - Albania 23
MY - Malesia 23
AT - Austria 22
LT - Lituania 22
CH - Svizzera 21
MA - Marocco 19
RO - Romania 19
JO - Giordania 18
NP - Nepal 17
SA - Arabia Saudita 16
DZ - Algeria 15
EG - Egitto 15
KE - Kenya 15
PE - Perù 14
PH - Filippine 14
PT - Portogallo 14
IL - Israele 13
IR - Iran 13
UY - Uruguay 13
BZ - Belize 12
OM - Oman 11
PY - Paraguay 11
AZ - Azerbaigian 10
KZ - Kazakistan 10
TN - Tunisia 10
RS - Serbia 9
DO - Repubblica Dominicana 8
ET - Etiopia 8
MD - Moldavia 8
BO - Bolivia 7
BY - Bielorussia 7
LB - Libano 7
PA - Panama 7
SI - Slovenia 7
TH - Thailandia 7
TW - Taiwan 7
SN - Senegal 6
CR - Costa Rica 5
CY - Cipro 5
GR - Grecia 5
LK - Sri Lanka 5
MT - Malta 5
SY - Repubblica araba siriana 5
DK - Danimarca 4
HR - Croazia 4
NG - Nigeria 4
PS - Palestinian Territory 4
AM - Armenia 3
BB - Barbados 3
EE - Estonia 3
GE - Georgia 3
HU - Ungheria 3
JM - Giamaica 3
KG - Kirghizistan 3
KH - Cambogia 3
LV - Lettonia 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
Totale 27.932
Città #
Stockholm 1.795
Ashburn 1.405
Singapore 1.385
Fairfield 1.345
Santa Clara 1.183
Southend 798
Chandler 745
Woodbridge 696
Hong Kong 692
Houston 611
San Jose 499
Seattle 479
Cambridge 437
Ann Arbor 422
Wilmington 420
Nyköping 346
Hefei 328
Beijing 304
Modena 299
London 273
Dearborn 263
Jacksonville 251
Los Angeles 244
New York 237
Ho Chi Minh City 222
Council Bluffs 219
Bologna 211
Helsinki 200
Hanoi 189
The Dalles 161
Chicago 154
Milan 140
Munich 136
Seoul 133
San Diego 130
Jakarta 121
Frankfurt am Main 107
Shanghai 98
Lauterbourg 84
Princeton 84
Moscow 79
Sofia 78
Izmir 77
Parma 66
São Paulo 65
Fremont 63
Orem 61
Dallas 58
Eugene 58
Buffalo 57
Dublin 56
Salt Lake City 50
Boardman 48
Brussels 48
Rome 47
Bremen 42
Phoenix 41
Guangzhou 38
Mexico City 38
Tokyo 38
Warsaw 37
Reggio Emilia 35
Da Nang 34
Montreal 34
Nuremberg 33
Chennai 32
San Giuliano Milanese 31
Columbus 30
Falls Church 30
Atlanta 29
Hillsboro 29
Denver 28
Haiphong 26
Johannesburg 26
Redwood City 26
Tampa 25
Amsterdam 24
Elk Grove Village 24
Grafing 23
Poplar 23
Rio de Janeiro 23
Brooklyn 22
Manchester 22
Baghdad 21
Des Moines 21
Lancaster 21
Ravenna 21
Redondo Beach 21
Sydney 21
Norwalk 20
Portsmouth 20
Tashkent 20
Toronto 20
San Francisco 19
Boston 18
Mumbai 18
Turku 18
Paris 17
Tirana 17
Dong Ket 16
Totale 19.929
Nome #
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. 2.189
CD271 Down-Regulation Promotes Melanoma Progression and Invasion in Three-Dimensional Models and in Zebrafish 491
CD271 Mediates Stem Cells to Early Progeny Transition in Human Epidermis 486
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy 458
In vivo editing of the human mutant Rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina 427
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance. 424
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 419
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 406
GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion. 404
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 392
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies 384
MSC and Tumors: Homing, Differentiation and Secretion Influence The Therapeutic Potentials 378
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 377
Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood 372
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 359
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 359
Combination of low doses of Enzastaurin and Lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines 356
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance 355
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 344
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 344
Proposal of a Novel Natural Biomaterial, the Scleral Ossicle, for the Development of Vascularized Bone Tissue In Vitro 334
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 333
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 331
Tumor Stroma Manipulation By MSC 325
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells. 323
METHOD FOR PRODUCTION OF ANTI-TUMOR TRAIL PROTEIN 321
WISP-2 expression induced by Teriparatide treatment affects in vitro osteoblast differentiation and improves in vivo osteogenesis 318
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 317
Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come? 308
Transportation conditions for prompt use of Ex Vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration 307
Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression 306
Detection of microparticles from human red blood cells by multiparametric flow cytometry 300
Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells. 294
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 294
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 293
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 289
GD2 CAR T cells against human glioblastoma 289
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 287
Understanding Tumor-Stroma Interplays for Targeted Therapies by Armed Mesenchymal Stromal Progenitors: The Mesenkillers. 285
Mesenchymal Stromal/Stem Cells from Tissue Repair to Destruction of Tumor Cells 282
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 279
CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells? 278
An adoptive immuno-gene therapy approach targeting neuroblastoma. 276
Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study 276
Surrounding pancreatic adenocarcinoma by killer mesenchymal stromal/stem cells 272
Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines. 272
Impact of HOXB7 overexpression on human adipose-derived mesenchymal progenitors 271
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 267
Effects of Enzastaurin, Alone or in Combination, on Signalling Pathway Controlling Growth and Survival of B-Cell Lymphoma Cell LinesBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4978 266
A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors 257
Human Herpes simplex 1 virus infection of endometrial decidual tissue-derived MSC alters HLA-G expression and immunosuppressive functions 254
IGF-1-mediated osteoblastic niche expansion enhances long-term hematopoietic stem cell engraftment after murine bone marrow transplantation 246
Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review 246
CRISPR-mediated T cell engineering against Non-Small Cell Lung Cancer 246
Autologous Marrow Mesenchymal Stem Cell Driving Bone Regeneration in a Rabbit Model of Femoral Head Osteonecrosis 241
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 240
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress 239
Scleral ossicles as natural biomaterials on which vascular-like network is promoted from Mouse Aortic Endothelial cells (MAECs): preliminary results 238
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 236
Challenging the efficacy of checkpoint inhibitors: a new 3D model for a precision medicine approach. 236
Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells 233
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 233
Cancer stem cells and their microenvironment. 229
Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma 228
Cancer stem cells and macrophages: molecular connections and future perspectives against cancer. 228
TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models 226
TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma 225
Author Correction: A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology (Scientific Reports, (2019), 9, 1, (7154), 10.1038/s41598-019-43613-9) 222
Staminali per la cura del tumore del pancreas: tra evidenze scienti che e possibile trasferimento clinico 220
New Perspectives in Different Gene Expression Profiles for Early and Locally Advanced Non-Small Cell Lung Cancer Stem Cells. 218
Stem cells and lung cancer : between advanced diagnostics and new therapeutics. 211
Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment 210
Sarcomas as a mise en abyme of Mesenchymal Stem Cells; exploiting interrelationships for cell mediated anticancer therapy 206
Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells 205
Impact of Mesenchymal Stromal/stem Cell Infusions on Circulating Inflammatory Biomarkers in COVID-19 Patients: Analysis of a Phase I-IIa Trial. 203
Deepening the knowledge of ros1 rearrangements in non-small cell lung cancer: Diagnosis, treatment, resistance and concomitant alterations 203
In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor–related apoptosis inducing ligand in osteosarcoma pre-clinical models 201
Immunotherapy: AUTOLOGOUS ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA 193
Cancer Stem Cells and Cell Cycle Genes as Independent Predictors of Relapse in Non-small Cell Lung Cancer: Secondary Analysis of a Prospective Study 187
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma 183
Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem/Stromal Cells in Regenerative Medicine 183
Human Adipose Mesenchymal Stromal/Stem Cells Improve Fat Transplantation Performance 182
Adoptive CAR T Cell Therapy Targeting GD2-Positive Cancers 179
CRISPR-Mediated Genome Editing to Redirect T Cells against Non-Small Cell Lung Cancer 177
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 168
CAR-modified killer MSC targeting GD2-positive Ewing sarcoma 165
Abstract A17: Challenging pancreatic ductal adenocarcinoma and its stroma by a combination of chemo and gene therapy: A preclinical study 161
Refining GMP-manufactured density gradient media for optimised mesenchymal stromal/stem cell isolation and expansion. 160
Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence 158
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 149
Anti-GD2 chimeric antigen receptor & trail modified mesenchymal progenitors as novel strategy against ewing’s sarcoma 145
Bone marrow derived mesenchymal stem/stromal cells transduced with full length human TRAIL repress the growth of rhabdomyosarcoma cells in vitro 145
The release of inflammatory mediators from acid-stimulated mesenchymal stromal cells favours tumour invasiveness and metastasis in osteosarcoma 142
Modulating endothelial adhesion and migration impacts stem cell therapies efficacy 131
Acid microenvironment promotes cell survival of human bone sarcoma through the activation of cIAP proteins and NF-κB pathway 126
5P Anti-GD2 chimeric antigen receptor & TRAIL modified mesenchymal progenitors as novel strategy against Ewing’s sarcoma 120
Persistency of Mesenchymal Stromal/Stem Cells in Lungs 118
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations 111
The Influence of Cancer Stem Cells on the Risk of Relapse in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Prospective Cohort Study 110
Targeting Cancer Stem Cells: New Perspectives for a Cure to Cancer 87
Totale 28.177
Categoria #
all - tutte 99.067
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.067


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021435 0 0 0 0 0 0 0 0 0 0 305 130
2021/20222.303 106 321 233 90 78 123 177 145 216 163 414 237
2022/20232.267 259 278 189 241 231 265 63 216 260 26 124 115
2023/20241.494 101 88 113 155 280 181 102 138 36 51 71 178
2024/20255.067 144 90 184 372 850 859 501 263 527 254 402 621
2025/202610.257 633 332 669 1.134 1.592 559 1.170 470 2.678 993 27 0
Totale 28.262